• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA DGUOK-AS1通过m6A修饰增加TRPM7稳定性促进非小细胞肺癌的生长和转移。

LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification.

作者信息

Feng Yimin, Wu Fengjuan, Wu Yuanning, Guo Zihan, Ji Xiang

机构信息

Department of Clinical Laboratory, The Second Hospital of Shandong University, 247 Beiyuan Street, Jinan, Shandong 250033, China.

Department of Pulmonary and Critical Care Medicine, Heze Municipal Hospital, Heze, Shandong 274031, China.

出版信息

Transl Oncol. 2023 Jun;32:101661. doi: 10.1016/j.tranon.2023.101661. Epub 2023 Apr 8.

DOI:10.1016/j.tranon.2023.101661
PMID:37037089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10120365/
Abstract

BACKGROUND

N6-methyladenosine (m6A) modification plays key roles in tumor progression. LncRNA deoxyguanosine kinase antisense RNA 1 (DGUOK-AS1) has been reported as a promoter in tumors, but its role and mechanism in non-small cell lung cancer (NSCLC) development remain uncertain.

METHODS

Cell proliferation, migration, invasion and angiogenesis were investigated via CCK-8, colony formation, transwell, and tube formation assays, respectively. The location of DGUOK-AS1 was detected via FISH assay. The interaction relationship among DGUOK-AS1, IGF2BP2 and TRPM7 was confirmed by RIP and MeRIP assays. The effects of DGUOK-AS1 on NSCLC growth and metastasis in vivo were investigated using xenograft and pulmonary metastatic models.

RESULTS

DGUOK-AS1 was upregulated in NSCLC. DGUOK-AS1 silencing inhibited NSCLC cell proliferation, migration, invasion and angiogenesis. DGUOK-AS1 was mostly expressed in cytoplasm, and positively regulated IGF2BP2. METTL3/IGF2BP2 axis could increase TRPM7 mRNA stability in m6A-dependent manner. TRPM7 overexpression reversed the inhibitive function of DGUOK-AS1 silencing on NSCLC development. DGUOK-AS1 knockdown suppressed NSCLC cell growth and metastasis in nude mice.

CONCLUSION

DGUOK-AS1 silencing restrains NSCLC cell growth and metastasis through decreasing TRPM7 stability via regulation of the METTL3/IGF2BP2-mediated m6A modification.

摘要

背景

N6-甲基腺苷(m6A)修饰在肿瘤进展中起关键作用。长链非编码RNA脱氧鸟苷激酶反义RNA 1(DGUOK-AS1)已被报道为肿瘤中的一个促进因子,但其在非小细胞肺癌(NSCLC)发生发展中的作用及机制仍不明确。

方法

分别通过CCK-8、集落形成、Transwell和管腔形成实验研究细胞增殖、迁移、侵袭和血管生成。通过荧光原位杂交(FISH)实验检测DGUOK-AS1的定位。通过RNA免疫沉淀(RIP)和甲基化RNA免疫沉淀(MeRIP)实验证实DGUOK-AS1、胰岛素样生长因子2 mRNA结合蛋白2(IGF2BP2)和瞬时受体电位阳离子通道M7(TRPM7)之间的相互作用关系。使用异种移植和肺转移模型研究DGUOK-AS1对NSCLC体内生长和转移的影响。

结果

DGUOK-AS1在NSCLC中上调。DGUOK-AS1沉默抑制NSCLC细胞增殖、迁移、侵袭和血管生成。DGUOK-AS1主要在细胞质中表达,并正向调节IGF2BP2。甲基转移酶样3(METTL3)/IGF2BP2轴可以以m6A依赖的方式增加TRPM7 mRNA的稳定性。TRPM7过表达逆转了DGUOK-AS1沉默对NSCLC发展的抑制作用。DGUOK-AS1敲低抑制了裸鼠体内NSCLC细胞的生长和转移。

结论

DGUOK-AS1沉默通过调控METTL3/IGF2BP2介导的m6A修饰降低TRPM7稳定性,从而抑制NSCLC细胞生长和转移。

相似文献

1
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification.长链非编码RNA DGUOK-AS1通过m6A修饰增加TRPM7稳定性促进非小细胞肺癌的生长和转移。
Transl Oncol. 2023 Jun;32:101661. doi: 10.1016/j.tranon.2023.101661. Epub 2023 Apr 8.
2
LncRNA DGUOK-AS1 Promotes Cell Progression in Lung Squamous Cell Carcinoma by Regulation of miR-653-5p/SLC6A15 Axis.长链非编码RNA DGUOK-AS1通过调控miR-653-5p/SLC6A15轴促进肺鳞状细胞癌的细胞进展。
Mol Biotechnol. 2025 Feb;67(2):734-745. doi: 10.1007/s12033-024-01088-8. Epub 2024 Feb 26.
3
[Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung Cancer].[METTL3介导m6A修饰的长链非编码RNA THAP7-AS1上调在促进肺癌发生中的作用及机制研究]
Zhongguo Fei Ai Za Zhi. 2024 Jan 2;26(12):919-933. doi: 10.3779/j.issn.1009-3419.2023.102.45.
4
METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.METTL3 通过诱导 HOXC6 m6A 修饰并通过 IGF2BP2 依赖性机制稳定其表达促进前列腺癌进展。
Mol Cell Biochem. 2024 Jul;479(7):1707-1720. doi: 10.1007/s11010-024-05023-y. Epub 2024 May 31.
5
METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.METTL3/IGF2BP2 轴通过调节 STAG3 的 m6A 修饰影响结直肠癌的进展。
Sci Rep. 2023 Oct 12;13(1):17292. doi: 10.1038/s41598-023-44379-x.
6
METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression.METTL3介导的SF3B4的m6A修饰通过增强LSM4表达促进非小细胞肺癌的发展。
Thorac Cancer. 2024 Apr;15(11):919-928. doi: 10.1111/1759-7714.15275. Epub 2024 Mar 10.
7
The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.m6A 甲基转移酶 METTL3 介导的 DEK mRNA 的 N6-甲基腺苷化修饰促进胃癌细胞生长和转移。
Int J Mol Sci. 2022 Jun 9;23(12):6451. doi: 10.3390/ijms23126451.
8
RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.RNA N6-甲基腺嘌呤阅读器 IGF2BP2 通过依赖 m6A 的方式稳定 slug mRNA,促进头颈部鳞状细胞癌细胞的淋巴转移和上皮-间充质转化。
J Exp Clin Cancer Res. 2022 Jan 3;41(1):6. doi: 10.1186/s13046-021-02212-1.
9
A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.A1BG-AS1 通过招募 IGF2BP2 以依赖 m6A 的方式上调 ABCB1 促进乳腺癌阿霉素耐药。
Sci Rep. 2023 Nov 25;13(1):20730. doi: 10.1038/s41598-023-47956-2.
10
Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.长链非编码RNA DLX6-AS1敲低通过微小RNA-16-5p/BMI1轴抑制非小细胞肺癌的肿瘤发生和进展。
Transl Cancer Res. 2021 Aug;10(8):3772-3787. doi: 10.21037/tcr-21-1240.

引用本文的文献

1
M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges.m6A RNA修饰:聚焦于非小细胞肺癌的进展、治疗策略及挑战
Front Oncol. 2025 Jul 16;15:1622359. doi: 10.3389/fonc.2025.1622359. eCollection 2025.
2
The therapeutic potential of RNA m(6)A in lung cancer.RNA m(6)A在肺癌中的治疗潜力。
Cell Commun Signal. 2024 Dec 31;22(1):617. doi: 10.1186/s12964-024-01980-5.
3
Novel insights into the interaction between IGF2BPs and ncRNAs in cancers.对癌症中IGF2BPs与非编码RNA相互作用的新见解。
Cancer Cell Int. 2024 Dec 28;24(1):437. doi: 10.1186/s12935-024-03591-z.
4
The role of N6-methyladenosine modification in tumor angiogenesis.N6-甲基腺苷修饰在肿瘤血管生成中的作用。
Front Oncol. 2024 Dec 3;14:1467850. doi: 10.3389/fonc.2024.1467850. eCollection 2024.
5
A review of current developments in RNA modifications in lung cancer.肺癌中RNA修饰的当前进展综述。
Cancer Cell Int. 2024 Oct 25;24(1):347. doi: 10.1186/s12935-024-03528-6.
6
Regulatory effect of N6-methyladenosine on tumor angiogenesis.N6-甲基腺苷对肿瘤血管生成的调控作用。
Front Immunol. 2024 Sep 4;15:1453774. doi: 10.3389/fimmu.2024.1453774. eCollection 2024.
7
Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions.肺癌中的非编码RNA和外泌体非编码RNA:对其功能的见解
Front Cell Dev Biol. 2024 May 27;12:1397788. doi: 10.3389/fcell.2024.1397788. eCollection 2024.
8
Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications.甲基转移酶样3与非小细胞肺癌的关联:发病机制、治疗耐药性及临床应用
Transl Lung Cancer Res. 2024 May 31;13(5):1121-1136. doi: 10.21037/tlcr-24-85. Epub 2024 May 24.
9
mA modification of lncRNA PHKA1-AS1 enhances Actinin Alpha 4 stability and promotes non-small cell lung cancer metastasis.长链非编码RNA PHKA1-AS1的mA修饰增强了辅肌动蛋白α 4的稳定性并促进非小细胞肺癌转移。
MedComm (2020). 2024 May 17;5(6):e547. doi: 10.1002/mco2.547. eCollection 2024 Jun.
10
Role of TRP channels in carcinogenesis and metastasis: Pathophysiology and regulation by non-coding RNAs.瞬时受体电位通道在致癌作用和转移中的作用:病理生理学及非编码RNA的调控
Noncoding RNA Res. 2023 Dec 18;9(2):359-366. doi: 10.1016/j.ncrna.2023.12.001. eCollection 2024 Jun.

本文引用的文献

1
HDAC1 overexpression promoted by METTL3-IGF2BP2 inhibits FGF21 expression in metabolic syndrome-related liver injury.METTL3-IGF2BP2 促进的 HDAC1 过表达抑制代谢综合征相关肝损伤中的 FGF21 表达。
Biochem Cell Biol. 2023 Feb 1;101(1):52-63. doi: 10.1139/bcb-2022-0314. Epub 2022 Dec 21.
2
LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis.LCAT1 是一种致癌的 LncRNA,通过稳定 IGF2BP2-CDC6 轴起作用。
Cell Death Dis. 2022 Oct 18;13(10):877. doi: 10.1038/s41419-022-05316-4.
3
IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.IGF2BP2 通过调节 m6A 修饰的 MEIS2 和 GATA6 促进卵巢子宫内膜异位症的进展。
Int J Biochem Cell Biol. 2022 Nov;152:106296. doi: 10.1016/j.biocel.2022.106296. Epub 2022 Sep 13.
4
ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.ZNF677 通过 N6-甲基腺苷和转录抑制 CDKN3 抑制肾细胞癌进展。
Clin Transl Med. 2022 Jun;12(6):e906. doi: 10.1002/ctm2.906.
5
lncRNA SLC9A3-AS1 Promotes Oncogenesis of NSCLC via Sponging microRNA-760 and May Serve as a Prognosis Predictor of NSCLC Patients.长链非编码RNA SLC9A3-AS1通过海绵吸附微小RNA-760促进非小细胞肺癌的肿瘤发生,并可能作为非小细胞肺癌患者的预后预测指标。
Cancer Manag Res. 2022 Mar 9;14:1087-1098. doi: 10.2147/CMAR.S352308. eCollection 2022.
6
LncRNA HOTAIR promotes proliferation, invasion and migration in NSCLC cells via the CCL22 signaling pathway.长链非编码 RNA HOTAIR 通过 CCL22 信号通路促进非小细胞肺癌细胞的增殖、侵袭和迁移。
PLoS One. 2022 Feb 17;17(2):e0263997. doi: 10.1371/journal.pone.0263997. eCollection 2022.
7
IGF2BP2 Regulates MALAT1 by Serving as an N6-Methyladenosine Reader to Promote NSCLC Proliferation.IGF2BP2通过作为N6-甲基腺苷阅读器调控MALAT1以促进非小细胞肺癌增殖。
Front Mol Biosci. 2022 Jan 17;8:780089. doi: 10.3389/fmolb.2021.780089. eCollection 2021.
8
An adipose lncRAP2-Igf2bp2 complex enhances adipogenesis and energy expenditure by stabilizing target mRNAs.一种脂肪lncRAP2-Igf2bp2复合物通过稳定靶mRNA增强脂肪生成和能量消耗。
iScience. 2021 Dec 25;25(1):103680. doi: 10.1016/j.isci.2021.103680. eCollection 2022 Jan 21.
9
FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-β signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1.FOXP3 激活的 LINC01232 通过激活 TGF-β 信号通路并募集 IGF2BP2 来稳定 TGFBR1,从而加速非小细胞肺癌的干性。
Exp Cell Res. 2022 Apr 15;413(2):113024. doi: 10.1016/j.yexcr.2022.113024. Epub 2022 Jan 10.
10
New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer.长非编码 RNA 与 RNA 结合蛋白在癌症中的相互作用的新见解。
Cancer Commun (Lond). 2022 Feb;42(2):117-140. doi: 10.1002/cac2.12254. Epub 2022 Jan 12.